upon the transgenic expression of DmDG (Fig.  2I) . Among mitochondrial dehydrogenases in insects, PDH is the only enzyme that is reported to show Ca 2+ -dependent activation (18), and therefore, it is possible that the reduced expression of DmDG causes the sustained increase in the [Ca 2+ ] i , which, in turn, induces the activation of PDH, resulting in increased mitochondrial oxidative metabolism. Based on these observations, we propose that a reduction in the DmDG content initiates a chain of sequential reactions, i.e., increased membrane fluidity, activation of Ca 2+ influx, elevated mitochondrial metabolism, and eventually, altered thermoregulatory behavior ( fig.  S9 ). It remains an enigma, however, how the metabolic changes in a cell are translated into neural code that induces behavioral change at the level of the whole animal (see also supporting online text). 4.2% (mean T SEM); "DmDG-knockdown" line (actin5C-GAL4/UAS-dsRNA), 59.0 T 3.6%; and control UAS-dsRNA line (+/UAS-dsRNA), 25.4 T 7.7%. Error bars represent SEM (n = 7). 22. Wild type, 1.6 T 0.1 (mean T SEM); atu mutant, 3.0 T 0.1; and DmDG-transgenic atu mutant (atu/atu; actin5C-GAL4/UAS-DmDG), 2.2 T 0.2. Error bars represent SEM (n = 6). 23. Wild type, 20.9 T 1.5 (mean T SEM; n = 9); atu mutant, 27.0 T 1.8 (n = 8); and DmDG-transgenic atu mutant (atu/atu; actin5C-GAL4/UAS-DmDG), 20.2 T 1.2 (n = 8).
24. Wild type, 15.7 T 0.4 (mean T SEM); atu mutant, 32.3 T 1.8; and DmDG-transgenic atu mutant (atu/atu; actin5C-GAL4/UAS-DmDG), 25.2 T 1.6 (n = 3). 25 . Wild type, 124.9 T 1.9 (mean T SEM; n = 202); atu mutant, 148.5 T 2.3 (n = 194); and DmDG-transgenic atu mutant (atu/atu; actin5C-GAL4/UAS-DmDG), 115.5 T 2.9 (n = 119). 26. Wild type, 139.0 T 4.7 (mean T SEM; n = 98); atu mutant, 151.8 T 7.4 (n = 88); and DmDG-transgenic atu mutant (atu/atu; actin5C-GAL4/UAS-DmDG), 101.9 T 6.3 (n = 79 Ronald E. Gordon, 2 Frank Y. S. Chuang, 3 Xiao-Dong Li, 4 David M. Asmuth, 4 Thomas Huser, 3, 4 Benjamin K. Chen 1 *
The spread of HIV between immune cells is greatly enhanced by cell-cell adhesions called virological synapses, although the underlying mechanisms have been unclear. With use of an infectious, fluorescent clone of HIV, we tracked the movement of Gag in live CD4 T cells and captured the direct translocation of HIV across the virological synapse. Quantitative, high-speed three-dimensional (3D) video microscopy revealed the rapid formation of micrometer-sized "buttons" containing oligomerized viral Gag protein. Electron microscopy showed that these buttons were packed with budding viral crescents. Viral transfer events were observed to form virus-laden internal compartments within target cells. Continuous time-lapse monitoring showed preferential infection through synapses. Thus, HIV dissemination may be enhanced by virological synapse-mediated cell adhesion coupled to viral endocytosis.
H uman immunodeficiency virus (HIV) infection leads to depletion of CD4 T cells throughout the lymphoid system. Both cell-free and cell-associated infection routes contribute to viral dissemination in vivo (1) . In vitro, infection with cell-associated HIV can be thousands fold more efficient than infection with cell-free virus (2) , and inhibition of cell-cell contacts severely limits replication (3). Infection through synapses between virus-carrying dendritic cells and CD4 T cells is highly efficient (4, 5) . For human T cell lymphotropic virus type I, viral synapses between T cells are essential for dissemination (6) . For HIV, infected and uninfected CD4 T cells form virological synapses that organize viral receptors CD4, CXCR4, and Env (7). These infectious contacts are regulated by cell adhesion through integrins and intercellular adhesion molecules (8), dynamic actin and tubulin (9) , cell signaling (10), and lipid raft recruitment (11) . T cell virological synapses transfer virus with high efficiency (12) , yet how this route fundamentally differs from cell-free infection remains unclear.
To examine the spatial and temporal organization of synapse formation, we used an infectious, fluorescent HIV clone, carrying a Gag-internal, interdomain insertion of the green fluorescent protein (GFP), called HIV Gag-iGFP (13) . This virus faithfully reveals Gag localization, allowing infected cells and viral particles to be tracked with high sensitivity (12) . Time-lapse fluorescence microscopy of virological synapse formation showed that 24% of HIV Gag-iGFP-expressing Jurkat cells formed stable adhesions to primary CD4 T cells within 4 hours ( Fig. 1 and table S1A ). After adhesion, 80% formed focal Gag accumulations at the contact site with an average 82-min interval (Fig. 1, A and B) . In contrast, an Env-deficient clone was unable to induce cell-cell conjugates or Gag accumulation (table S1B), illustrating that adhesion precedes Gag redistribution.
In fixed samples, high-resolution confocal imaging revealed prominent Gag accumulations at the synapse (Fig. 1C) . In three-dimensional (3D) reconstructions, these appeared as button-shaped discs, 1 to 3 mm in diameter ( Fig. 1D and movie S1). Synaptic buttons were also observed in HIV Gag-iGFP-expressing primary CD4 T cells cocultured with homologous primary CD4 cells ( fig.  S1 ). We assessed viral assembly at the synapse by measuring Gag oligomerization with fluorescence resonance energy transfer (FRET) (13) (14) (15) between Cerulean and Venus variants of HIV Gag-iGFP, which form a donor-acceptor FRET pair (16) . Excitation of the Cerulean donor in cotransfected Jurkat cells generated a robust Venusshifted FRET signal at synaptic buttons that is indicative of Gag homo-oligomerization (Fig. 1E) . Photobleaching the Venus acceptor at a synapse lead to increased donor emission, providing additional evidence for FRET (Fig. 1, F to H, and  fig. S2 ). Three-dimensional reconstruction of FRET images revealed concentrated Gag oligomerization at synapses (movie S2).
With transmission electron microscopy, we observed that 100-nm budding viral crescents at the virological synapse protruded from the donor cell with bud tips directly abutting the target cell membrane (Fig. 1I ). Viral buds were also observed far from the synapse, although at lower densities ( fig. S3 ). Native, non-GFP-expressing HIV induced similar budding crescents, ruling out that GFP induced these accumulations ( fig.  S4 ). In thick 150-nm sections, near-complete viral buds and a virus-containing invagination in the synapsed target cell were observed (fig. S4, A and B).
To capture the dynamics of Gag trafficking, reorganization, and viral transfer with higher temporal and spatial resolution, we recorded highspeed, spinning disc confocal fluorescence images. Forty-three putative synaptic events encompassing 1187 min revealed dynamic Gag movements during virological synapse formation (table S2) . New synaptic button formation (n = 4) was captured where patches of membrane-associated Gag moved toward the cell adhesion site within minutes ( Fig. 2A and movie S3). At existing buttons, a ring-shaped zone of Gag depletion often surrounded the synaptic button (Fig. 2B ), indicative of a synapse-proximal region from which Gag was recruited.
HIV Gag-iGFP-labeled structures (n = 8) close to existing buttons moved rapidly and directionally into the button (Fig. 2C, fig. S5 , and movies S4 to S6). The structures moved into the synapse with average velocities of 0.10 to 0.25 mm/s and peaks up to 0.8 mm/s (Fig. 2C and fig. S5 ). Other small, mobile Gag puncta emerged from and then moved back into the synaptic button ( Fig.  2D and movie S7). The fast, directional movement of Gag was seen predominantly from nearby puncta.
During cell-to-cell viral transfer (n = 10, table S2), fluorescent Gag signal protruded from buttons, penetrated the attached target cell, was released into the target cell, and then migrated distally with a mean velocity of 0.12 mm/s (Fig.  2E and movie S8). Notably, puncta 1.5 mm in diameter were observed ( fig. S6A ), and on occasion an entire synaptic button was transferred (movie S9). Large vesicular structures were also observed to fractionate into smaller vesicles while moving toward the distal pole of the cell (movies S4 and S8). The size of these translocated puncta exceeds individual clathrin-or caveolin-associated structures, which are uniformly small (100 to 200 nm) (17) . By using quantitative confocal microscopy, we found that the accumulation and maintenance of Gag puncta in target cells was remarkably stable over time ( fig. S6 , B to D, and movie S10).
The GFP signal in flow-sorted HIV+ CD4 target cells was uniformly punctate, without evidence of syncitia, and confocal imaging suggested that puncta were not surface-associated ( fig. S7 ). AntiEnv staining of the Gag-iGFP puncta required cell permeabilization, indicating that Env was present in an internal Gag+ compartment (Fig. 2, F and G). Transmission electron microscopy of the target cells revealed multivesicular structures, which were not seen in control, unexposed cells, that contained viruslike densities inside 1-to 2-mm compartments (Fig. 2H) . We conclude that synapses target HIV into vesicular compartments within recipient cells.
To track the fate of cells after synapse formation, we performed continuous, long-duration imaging. Jurkat donor cells were cotransfected with HIV Gag-iGFP and HIV NL-GI, an HIV molecular clone that expresses GFP in place of the viral early gene nef (18) (Fig. 3, A C , and movie S11). Bystander target cells remained negative. Over 67 hours, 112 conjugates tracked resulted in seven productively infected MT4 target cells (table S3) . In five cases, synapses were observed, and in four cases virus transfer was recorded (Fig. 3 , A to C, and movie S12). Under culture conditions that limited new cell-cell interactions, productively infected cells arose preferentially after observed virological synapse events.
Because synapse-mediated viral transfer is coreceptor-independent (12, 19), we tested whether infection through T cell synapses requires coreceptor expression. Infection of MT4 cells by cellassociated HIV was inhibited when cells were separated by a 0.4-mm transwell barrier (Fig. 4A ).
Under these contact-dependent infection conditions, productive infection by cell-associated HIV NL-GI was inhibited by CXCR4-antagonist, AMD3100 (Fig. 4B) . Furthermore, productive infection by cell-associated R5-tropic virus HIV NL-GI (JRFL) was dependent on expression of the chemokine receptor, CCR5 (Fig. 4C) . The results suggest that infection through T cell synapses does not bypass the coreceptor requirement.
Synapse-mediated viral transfer is potently inhibited by actin inhibitors such as cytochalasin D (9, 12). We find that cytochalasin D had little effect on cell-free HIV infection yet effectively inhibited productive infection by cell-associated HIV (Fig. 4D) . Additionally, a well-characterized patient antisera, which can potently block cellfree infection but not transfer of virus through virological synapses (12), did not efficiently block infection of the homologous cell-associated virus (Fig. 4E) . Thus, inhibitor studies clearly distinguish the mechanisms of cell-free from those of cell-associated infection.
The infection (20) (21) (22) , our results suggest that the cellto-cell transmission could favor endocytic routes. Thus when spreading via synapses, it is possible that HIV resembles a majority of viruses that enter preferentially through endocytosis (e.g., influenza, adenoviruses, picornaviruses, alphaviruses) (23) . Given this scenario, the tight coupling of Env fusogenicity with particle maturation (24, 25) may activate viral fusion within a target cell compartment that is cloistered from neutralizing antibodies (12) . Alternatively, the prominent endocytic process that accompanies synapse formation may create viral reservoirs in intracellular compartments. Future vaccine strategies may be focused against unique cell-surface Env epitopes that block cell-associated infection, and future antiviral drugs may target factors required for synapse formation. Ultimately the dynamics of virological synapse formation must be understood within lymphoid tissues, where high density and lymphocyte mobility (26) are likely to promote synaptic viral spread. 1 * Human colorectal cancers (CRCs) display a large number of genetic and epigenetic alterations, some of which are causally involved in tumorigenesis (drivers) and others that have little functional impact (passengers). To help distinguish between these two classes of alterations, we used a transposon-based genetic screen in mice to identify candidate genes for CRC. Mice harboring mutagenic Sleeping Beauty (SB) transposons were crossed with mice expressing SB transposase in gastrointestinal tract epithelium. Most of the offspring developed intestinal lesions, including intraepithelial neoplasia, adenomas, and adenocarcinomas. Analysis of over 16,000 transposon insertions identified 77 candidate CRC genes, 60 of which are mutated and/or dysregulated in human CRC and thus are most likely to drive tumorigenesis. These genes include APC, PTEN, and SMAD4. The screen also identified 17 candidate genes that had not previously been implicated in CRC, including POLI, PTPRK, and RSPO2. R ecent genomic studies have revealed that human colorectal cancers (CRCs) undergo numerous genetic and epigenetic alterations (1-4). These alterations probably derive from a mixture of "drivers" that play a causal role in tumor formation and progression and "passengers" that have little or no effect on tumor growth. The design of targeted therapeutics for CRCs is dependent on the ability to distinguish drivers from passengers.
To help identify potential driver genes in CRC, we developed a forward genetic screen in mice by using a Sleeping Beauty (SB) system to generate insertional mutations. To confine transposition to the gastrointestinal tract, SB11 transposase cDNA, preceded by a LoxP-flanked stop cassette, was knocked into the Rosa26 locus ( fig. S1) (5) . These mice were then crossed with Villin-Cre transgenic mice to activate SB transposase in epithelial cells of the gastrointestinal tract (6). Once expressed, SB transposase catalyzed the transposition of T2/Onc, a mutagenic SB transposon (Fig.  1A) (7) . T2/Onc contains a murine stem-cell virus long terminal repeat and splice donor site (MSCV-LTR-SD), which can deregulate the expression of a nearby proto-oncogene. T2/Onc also carries splice acceptor sites in both DNA strands and a bidirectional polyadenylate signal, which can inactivate the expression of a tumor suppressor gene. Because SB transposition is biased toward reintegration of the transposon into the same chromosome as the donor transposon (a phenomenon referred to as "local hopping"), we used two T2/Onc transgenic lines that each carried approximately 25 copies of the T2/Onc transposon in a concatamer on different donor chromosomes (chrs 1 and 15) (7) .
A histochemical analysis of the triple transgenic mice (Rosa26-LsL-SB11, T2/Onc, and VillinCre) showed that SB transposase was strongly expressed in epithelial cells of the gut and pancreas but undetectable in other tissues ( fig. S2 ). We created a cohort of 28 triple transgenic mice and 72 double transgenic control mice carrying all possible dual combinations of the three transgenes. Mice in this first cohort were monitored daily for 18 months. We generated a second cohort of 50 triple transgenic mice that were maintained in a separate facility for 12 months and also monitored daily.
Triple transgenic mice died at a faster rate than double transgenic controls, beginning around one year of age (Fig. 1B) . Examination of the gastrointestinal tract of moribund animals revealed discrete raised lesions ranging from 2 mm to as large as 5 mm in diameter in the small and large intestine. In the first cohort, 100% (12 out of 12) www.sciencemag.org SCIENCE VOL 323 27 MARCH 2009 
